리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 09월
페이지 정보:영문 168 Pages
라이선스 & 가격 (부가세 별도)
한글목차
바이러스성 간염 및 레트로바이러스 진단 검사 세계 시장, 2030년에는 77억 달러에 이를 전망
2023년에 44억 달러로 추정되는 바이러스성 간염 및 레트로바이러스 진단 검사 세계 시장은 2023-2030년간 CAGR 8.4%로 성장하여 2030년에는 77억 달러에 이를 것으로 예측됩니다.
미국 시장은 12억 달러, 중국은 CAGR 11.3%로 성장할 것으로 예측
미국 바이러스성 간염 및 레트로바이러스 진단 검사 시장은 2023년에는 12억 달러에 이른 것으로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 17억 달러 규모에 이를 것으로 예측되어 2023년부터 2030년까지 분석 기간 CAGR은 11.3%입니다. 기타 주목해야 할 지역 시장으로서는 일본과 캐나다가 있으며, 각각 2023-2030년간 5.5%와 6.9%의 성장이 예측됩니다. 유럽에서는 독일이 CAGR 약 6.5%로 성장할 것으로 예측됩니다.
2024년 신규 보고서의 특징
인플루언서 참여 통계에 대한 전체 액세스 권한
디지털 아카이브 및 "MarketGlass" 리서치 플랫폼에 무료로 액세스하세요. 전 세계 도메인 전문가들의 창의성과 시장 지식을 응집력 있고 협업적인 방식으로 활용할 수 있는 독점적인 MarketGlass 플랫폼이 완벽하게 지원됩니다. 당사의 최첨단 도구는 참가자의 개인정보와 신원을 보호하면서 세계적 수준의 시장 관점을 제공합니다. 보고서의 수치, 통계 및 시장 설명은 해당 분야의 전문가와 인플루언서가 공유한 엄선된 인사이트를 기반으로 합니다.
실시간 데이터 시뮬레이터 도구 및 맞춤형 보고서 생성 기능과 함께 제공되는 대화형 설문지에 참여할 있습니다.
기업 간 스마트한 의견 교환을 위한 동료 협업 및 대화형 플랫폼에 대한 전체 클라이언트 액세스 권한 부여
금융긴축과 그에 따른 금리 상승에 의한 지정학적인 영향과 경제 불안정성이, 2024년 세계 경제를 파란으로 가득 찬 것으로 한다고 생각됩니다. 중동의 적대 행위와 점점 더 빈번해지는 기후 재난 등 여러 요인이 복구의 길에 계속 압력을 가할 것입니다. 이러한 리스크 가운데 디스인플레이션의 조짐과 고질적인 인플레이션에 대한 불안감 완화, 공급망 정상화, 에너지 비용의 변동성에도 불구하고 가격 조정 등 몇 가지 긍정적인 요소도 구체화되고 있습니다. 인도나 미국을 비롯한 G21 국가 선거는 자본 흐름이나 투자 전략에 영향을 미칠 가능성이 있습니다. 인도가 글로벌 투자 환경에서 매력적인 투자처로 부상하고 있지만, 미국에 기반을 둔 기술 기업들은 역동적인 인재와 자본 생태계에 힘입어 계속해서 우위를 점할 것입니다. 실리콘밸리를 시작으로 하는 하이테크 기업 투자 기회는 국내 경제가 감속하고 있다고는 해도 안정적이고, 규제 환경도 정비되고 있는 것부터, 고성장 가능성을 요구하는 투자자에 있어서 계속 매력적입니다. 유럽은 금융긴축 정책과 경기후퇴 리스크와의 싸움이 계속 되지만, 영국은 전망이 가장 어둡고, 2024년 경기후퇴 리스크가 가장 높습니다. 중국은 정부 지출과 소비자 지출의 개선에 힘입어 성장에 대한 희망을 품고 있는 와일드카드로 남아 있습니다. 변동성이 큰 환경은 투자자와 기업 모두에게 기회와 도전을 동시에 제공할 것입니다. 투자 결정을 내릴 때 민첩성과 전략적 선견지명과 함께 변동성을 성장의 촉매제로 받아들이는 것이 생존을 위해 여전히 중요할 것입니다.
조사 대상 기업 예(총 31건)
Abbott Diagnostics
Amkay Products
AOV International
Apothecaries Sundries Manufacturing
BD
Beckman Coulter
Bhat Bio-tech
BioMerieux
Bioneovan
Bio-Rad
Cepheid
Chembio
DiaSorin
Enzo Biochem
Fujirebio
Gemc Technology
Grifols
Hangzhou Deangel Biological Engineering
Hangzhou Heo Bio-Tech
Hologic
Horiba
Innovation Biotech
Jaksh Enterprises
Krishco Medical Products
Roche Diagnostics
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트(UAE)
기타 중동
아프리카
제4장 경쟁
LSH
영문 목차
영문목차
Global Viral Hepatitis and Retrovirus Diagnostic Tests Market to Reach $7.7 Billion by 2030
The global market for Viral Hepatitis and Retrovirus Diagnostic Tests estimated at US$4.4 Billion in the year 2023, is expected to reach US$7.7 Billion by 2030, growing at a CAGR of 8.4% over the period 2023-2030.
The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow at 11.3% CAGR
The Viral Hepatitis and Retrovirus Diagnostic Tests market in the U.S. is estimated at US$1.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 11.3% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.5% and 6.9% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.
Introducing Our Exciting New Report Features for 2024
Full access to influencer engagement stats
Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
Complimentary report updates for one year
Competitor coverage with global market shares of major players
Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes
What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.
Select Competitors (Total 31 Featured) -
Abbott Diagnostics
Amkay Products
AOV International
Apothecaries Sundries Manufacturing
BD
Beckman Coulter
Bhat Bio-tech
BioMerieux
Bioneovan
Bio-Rad
Cepheid
Chembio
DiaSorin
Enzo Biochem
Fujirebio
Gemc Technology
Grifols
Hangzhou Deangel Biological Engineering
Hangzhou Heo Bio-Tech
Hologic
Horiba
Innovation Biotech
Jaksh Enterprises
Krishco Medical Products
Roche Diagnostics
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Viral Hepatitis and Retrovirus Diagnostic Tests - Global Key Competitors Percentage Market Share in 2024 (E)
Global Economic Update
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 4: World Viral Hepatitis and Retrovirus Diagnostic Tests Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 5: USA Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 6: USA Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
CANADA
TABLE 7: Canada Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 8: Canada Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
JAPAN
Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 9: Japan Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 10: Japan Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
CHINA
Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 11: China Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 12: China Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
EUROPE
Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 13: Europe Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 14: Europe Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 15: Europe 16-Year Perspective for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
FRANCE
Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 16: France Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 17: France Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
GERMANY
Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 18: Germany Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 19: Germany Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
ITALY
TABLE 20: Italy Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 21: Italy Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
UNITED KINGDOM
Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 22: UK Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 23: UK Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
SPAIN
TABLE 24: Spain Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 25: Spain Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
RUSSIA
TABLE 26: Russia Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 27: Russia Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
REST OF EUROPE
TABLE 28: Rest of Europe Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 29: Rest of Europe Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
ASIA-PACIFIC
Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 30: Asia-Pacific Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 31: Asia-Pacific Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 32: Asia-Pacific 16-Year Perspective for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
AUSTRALIA
Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 33: Australia Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 34: Australia Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
INDIA
Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 35: India Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: India Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
SOUTH KOREA
TABLE 37: South Korea Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 38: South Korea Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
REST OF ASIA-PACIFIC
TABLE 39: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 40: Rest of Asia-Pacific Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
LATIN AMERICA
Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 41: Latin America Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 42: Latin America Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: Latin America 16-Year Perspective for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
ARGENTINA
TABLE 44: Argentina Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: Argentina Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
BRAZIL
TABLE 46: Brazil Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 47: Brazil Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
MEXICO
TABLE 48: Mexico Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 49: Mexico Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
REST OF LATIN AMERICA
TABLE 50: Rest of Latin America Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Rest of Latin America Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
MIDDLE EAST
Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 52: Middle East Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 53: Middle East Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 54: Middle East 16-Year Perspective for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
IRAN
TABLE 55: Iran Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 56: Iran Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
ISRAEL
TABLE 57: Israel Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 58: Israel Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
SAUDI ARABIA
TABLE 59: Saudi Arabia Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: Saudi Arabia Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
UNITED ARAB EMIRATES
TABLE 61: UAE Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 62: UAE Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
REST OF MIDDLE EAST
TABLE 63: Rest of Middle East Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 64: Rest of Middle East Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
AFRICA
Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 65: Africa Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: Africa Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
IV. COMPETITION
(주)글로벌인포메이션02-2025-2992kr-info@giikorea.co.kr ⓒ Copyright Global Information, Inc. All rights reserved.